The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Roumell Asset Management, Llc since 2006.
The trader's CIK number is 1331693.
At the time of the last reporting, Roumell Asset Management, Llc was the 10% Owner of Paratek Pharmaceuticals, Inc.. (stock ticker symbol PRTK).
Also see all insider trading activities at Paratek Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2006 | PTM | 164,250 | $1,329,034 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | TSPT | 0 | $0 | 61,880 | $221,802 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | TECUB | 0 | $0 | 80,050 | $631,779 | 0 | $0 |
1. Putnam Managed High Yield Trust (PTM)
2. Paratek Pharmaceuticals, Inc. (TSPT)
3. Tecumseh Products Co (TECUB)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2006-03-03 | PTM | Buy | 14,600 | 8.15 | 118,990 |
| 2006-03-02 | PTM | Buy | 1,500 | 8.15 | 12,225 |
| 2006-03-01 | PTM | Buy | 3,700 | 8.15 | 30,155 |
| 2006-02-28 | PTM | Buy | 3,100 | 8.15 | 25,265 |
| 2006-02-27 | PTM | Buy | 10,050 | 8.15 | 81,907 |
| 2006-02-24 | PTM | Buy | 23,500 | 8.10 | 190,256 |
| 2006-03-13 | PTM | Buy | 46,000 | 8.05 | 370,530 |
| 2006-03-09 | PTM | Buy | 15,950 | 8.04 | 128,158 |
| 2006-03-10 | PTM | Buy | 12,000 | 8.15 | 97,764 |
| 2006-03-08 | PTM | Buy | 17,000 | 8.05 | 136,867 |
| 2006-03-07 | PTM | Buy | 10,500 | 8.11 | 85,165 |
| 2006-03-06 | PTM | Buy | 6,350 | 8.15 | 51,752 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-12-13 | TSPT | Sale | 1,470 | 3.54 | 5,203 |
| 2013-12-10 | TSPT | Sale | 9,470 | 3.55 | 33,656 |
| 2013-12-11 | TSPT | Sale | 1,020 | 3.55 | 3,622 |
| 2013-12-06 | TSPT | Sale | 8,710 | 3.54 | 30,842 |
| 2013-12-04 | TSPT | Sale | 5,450 | 3.50 | 19,075 |
| 2013-12-03 | TSPT | Sale | 1,670 | 3.50 | 5,845 |
| 2013-11-18 | TSPT | Sale | 5,440 | 3.57 | 19,426 |
| 2013-11-20 | TSPT | Sale | 1,540 | 3.61 | 5,559 |
| 2013-11-19 | TSPT | Sale | 3,060 | 3.55 | 10,863 |
| 2013-11-08 | TSPT | Sale | 3,630 | 3.56 | 12,922 |
| 2013-11-12 | TSPT | Sale | 3,560 | 3.50 | 12,477 |
| 2013-11-04 | TSPT | Sale | 2,380 | 3.75 | 8,925 |
| 2013-10-30 | TSPT | Sale | 550 | 3.85 | 2,117 |
| 2013-10-29 | TSPT | Sale | 1,070 | 3.75 | 4,012 |
| 2013-10-28 | TSPT | Sale | 5,400 | 3.66 | 19,764 |
| 2013-10-07 | TSPT | Sale | 750 | 3.60 | 2,701 |
| 2013-09-25 | TSPT | Sale | 6,710 | 3.69 | 24,793 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-02-28 | TECUB | Sale | 2,010 | 8.86 | 17,800 |
| 2013-02-27 | TECUB | Sale | 830 | 8.99 | 7,461 |
| 2013-02-28 | TECUA | Sale | 10,670 | 9.17 | 97,875 |
| 2013-02-27 | TECUA | Sale | 3,700 | 9.23 | 34,158 |
| 2013-02-22 | TECUA | Sale | 4,020 | 9.13 | 36,686 |
| 2013-02-25 | TECUA | Sale | 3,510 | 9.24 | 32,442 |
| 2013-02-26 | TECUA | Sale | 60 | 9.05 | 543 |
| 2013-02-22 | TECUB | Sale | 670 | 9.03 | 6,050 |
| 2013-02-26 | TECUB | Sale | 690 | 8.85 | 6,106 |
| 2013-02-11 | TECUA | Sale | 8,320 | 7.97 | 66,343 |
| 2013-02-11 | TECUB | Sale | 1,380 | 8.18 | 11,287 |
| 2013-02-06 | TECUA | Sale | 11,200 | 7.77 | 87,046 |
| 2013-02-06 | TECUB | Sale | 2,030 | 8.08 | 16,408 |
| 2013-02-06 | TECUA | Sale | 11,200 | 7.77 | 87,046 |
| 2013-02-01 | TECUA | Sale | 3,370 | 7.12 | 23,984 |
| 2013-02-01 | TECUB | Sale | 370 | 7.20 | 2,664 |
| 2013-01-28 | TECUA | Sale | 7,180 | 7.15 | 51,351 |
| 2013-01-28 | TECUB | Sale | 1,020 | 7.30 | 7,449 |
| 2013-01-15 | TECUB | Sale | 1,110 | 4.95 | 5,490 |
| 2013-01-15 | TECUA | Sale | 6,710 | 5.01 | 33,590 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Roumell Asset Management, Llc (10% Owner of Paratek Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.